Results 41 to 50 of about 29,309,204 (245)
Utility of non-HDL-C and apoB targets in the context of new more aggressive lipid guidelines
Major guidelines recommend the use of secondary targets, such as non-HDL-C and apoB, to further reduce cardiovascular risk. We aimed to evaluate the proportion at which newer, more aggressive secondary lipid targets are exceeded in patients with LDL-C
Renato Quispe +9 more
openaire +3 more sources
Correlation between miR-379 and T-Chol, LDL-C, non-HDL-C and ALP levels.
Linear regression analysis was used to examine correlations between serum miR-379 levels and clinicopathologic parameters. Left, middle, and right columns present the results for the NAFLD early stage, NAFLD advanced stage groups and normal control group,
Keisuke Hino (156607) +19 more
core +1 more source
Non-HDL-C/TC ratio: A useful screenings test for dysbetalipoproteinemia
Familial dysbetalipoproteinemia (FD) is a genetic lipid disorder, caused by a mutation in the apolipoprotein E (APOE) gene, and characterized by an increased number of cholesterol-enriched remnant lipoproteins in the plasma and premature cardiovascular disease.
Koopal, Charlotte +3 more
openaire +3 more sources
BACKGROUND AND AIMS: Lipid ratios to estimate atherosclerotic disease risk in overweight/obese children are receiving great attention. We aimed to compare the performance of non-high-density lipoprotein-cholesterol (HDL-C) versus triglycerides-to-HDL-C ...
Grugni, G +21 more
core +3 more sources
ObjectiveWe aimed to characterize the relationship of a combination of circulating non-high-density lipoprotein-cholesterol (non-HDL-C) concentration and brachial-ankle pulse wave velocity (baPWV) with cardiovascular disease (CVD).MethodsWe performed a ...
Qiongbing Zheng +17 more
doaj +1 more source
Evaluation of triglyceride: HDL-C ratio and Non-HDL-C as harbingers of increased cardiovascular risk in metabolic syndrome [PDF]
Background: Metabolic syndrome is an aggregate of conditions that together increases the risk of developing cardiovascular disease and type 2 diabetes mellitus.
R., Dharuni +3 more
core +1 more source
Background Total occlusion is the most severe coronary lesion, indicating heavy ischemic burden and poor prognosis. The lipid profile is central to the development of atherosclerotic coronary lesions. Evidence on the optimal lipid measure to be monitored
Tianyu Li +13 more
doaj +1 more source
Discordance of Low-Density Lipoprotein Cholestrol and Non-High-Density Lipoprotein Cholestrol and Coronary Artery Disease Severity [PDF]
Background: A sizeable proportion of patients have discordant low-density lipoprotein cholesterol (LDL-C) and non-high-density lipoprotein cholesterol (non-HDL-C).
Ozge Kurmus +4 more
doaj +3 more sources
The association between novel atherogenic indices (NAIs) and the pathophysiology of metabolic dysfunction-associated steatotic liver disease (MASLD) has been extensively researched. Among these, non-high-density lipoprotein cholesterol (non-HDL-C) and non-HDL-C/HDL-C ratio are novel indices linked to a higher risk for metabolic syndrome - and possibly ...
Esmaeili, Shirin +6 more
openaire +2 more sources
Abstract Background In general, the identification of cholesterol-depleted lipid particles can be inferred from non-high-density lipoprotein cholesterol (non-HDL-C) concentration to apolipoprotein B (apoB) concentration ratio, which serves as a reliable indicator for assessing the risk of ...
Kerui Zhang +8 more
openaire +3 more sources

